136 related articles for article (PubMed ID: 11823127)
1. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.
León A; Rey A; Mallo L; Pirmettis I; Papadopoulos M; León E; Pagano M; Manta E; Incerti M; Raptopoulou C; Terzis A; Chiotellis E
Nucl Med Biol; 2002 Feb; 29(2):217-26. PubMed ID: 11823127
[TBL] [Abstract][Full Text] [Related]
2. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
3. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Tsoukalas Ch; Nikoladou L; Drossopoulou G; Dalla C; Pelecanou M; Papadopoulou-Daifotis Z; Papadopoulos M; Chiotellis E
Nucl Med Biol; 2002 Nov; 29(8):825-32. PubMed ID: 12453592
[TBL] [Abstract][Full Text] [Related]
4. Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.
Tsoukalas C; Pirmettis I; Patsis G; Pelecanou M; Bodo K; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
J Inorg Biochem; 2003 Jan; 93(3-4):213-20. PubMed ID: 12576284
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
[TBL] [Abstract][Full Text] [Related]
6. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations.
Johannsen B; Scheunemann M; Spies H; Brust P; Wober J; Syhre R; Pietzsch HJ
Nucl Med Biol; 1996 May; 23(4):429-38. PubMed ID: 8832697
[TBL] [Abstract][Full Text] [Related]
7. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
Bouziotis P; Pirmettis I; Pelecanou M; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
Chemistry; 2001 Sep; 7(17):3671-80. PubMed ID: 11575768
[TBL] [Abstract][Full Text] [Related]
8. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
Pirmettis IC; Papadopoulos MS; Chiotellis E
J Med Chem; 1997 Aug; 40(16):2539-46. PubMed ID: 9258360
[TBL] [Abstract][Full Text] [Related]
9. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of a novel "3 + 1" mixed ligand 99mTc complex having an aliphatic thiol as coligand.
Rey A; Papadopoulos M; Leon E; Mallo L; Pirmettis Y; Manta E; Raptopoulou C; Chiotellis E; Leon A
Appl Radiat Isot; 2001 Mar; 54(3):429-34. PubMed ID: 11214877
[TBL] [Abstract][Full Text] [Related]
11. Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluation.
Papadopoulos M; Nock B; Maina T; Pirmettis I; Raptopoulou C; Tasiopoulos A; Troganis A; Kabanos T; Terzis A; Chiotellis E
J Biol Inorg Chem; 2001 Feb; 6(2):159-65. PubMed ID: 11293409
[TBL] [Abstract][Full Text] [Related]
12. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
Mastrostamatis SG; Papadopoulos MS; Pirmettis IC; Paschali E; Varvarigou AD; Stassinopoulou CI; Raptopoulou CP; Terzis A; Chiotellis E
J Med Chem; 1994 Sep; 37(20):3212-8. PubMed ID: 7932548
[TBL] [Abstract][Full Text] [Related]
13. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
[TBL] [Abstract][Full Text] [Related]
14. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
Tsoukalas C; Papadopoulos MS; Maina T; Pirmettis IC; Nock BA; Raptopoulou C; Terzis A; Chiotellis E
Nucl Med Biol; 1999 Apr; 26(3):297-304. PubMed ID: 10363801
[TBL] [Abstract][Full Text] [Related]
15. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.
Friebe M; Mahmood A; Bolzati C; Drews A; Johannsen B; Eisenhut M; Kraemer D; Davison A; Jones AG
J Med Chem; 2001 Sep; 44(19):3132-40. PubMed ID: 11543682
[TBL] [Abstract][Full Text] [Related]
16. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Drews A; Pietzsch HJ; Syhre R; Seifert S; Varnäs K; Hall H; Halldin C; Kraus W; Karlsson P; Johnsson C; Spies H; Johannsen B
Nucl Med Biol; 2002 May; 29(4):389-98. PubMed ID: 12031873
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.
Nock BA; Maina T; Yannoukakos D; Pirmettis IC; Papadopoulos MS; Chiotellis E
J Med Chem; 1999 Mar; 42(6):1066-75. PubMed ID: 10090789
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biodistribution of two novel 99mTc( SNN/S) "3+1" mixed ligand complexes as potential brain perfusion agents.
Duan XH; Lu GX; Wang XB
Appl Radiat Isot; 2003; 59(2-3):119-24. PubMed ID: 12941499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
